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Immunoglobulin (Ig)E-mediated allergic reac-
tions to food proteins may induce a variety of
cutaneous, gastrointestinal, and systemic
symptoms in humans, rodents, pets, and farm
animals. The normal immune response to
dietary proteins is an increased mucosal
immunity associated with an active suppres-
sion of the systemic response. Given the oblig-
ate exposure of the gastrointestinal tract to
food proteins and potential antigens/allergens,
it is not surprising that this organ system has
evolved to provide defense mechanisms that
prevent foreign, intact proteins from gaining
entry into the body and access to the immune
system.
In discussions of food allergy, the
predominant hypothesis is that there is an
adverse reaction to exogenous food proteins
or food protein fragments, which escape
lumen hydrolysis and are thus available for
exposure to the gastrointestinal-associated
lymphoid tissues (GALT). Food or food con-
stituents are normally degraded by digestive
enzymes in the gastrointestinal tract, begin-
ning in the mouth and stomach and ulti-
mately completed in the small intestine.
Although the sensitizing mechanisms are
unknown for food allergens, intact or frag-
ments of proteins are proposed to be
absorbed by the gut mucosa, processed by
immunocompetent cells, and then presented
to the immune system. In a polarized helper
T cell subset 2 (Th2) environment, Ig class
switching to allergen-speciﬁc IgE is generated.
The mechanisms and what determines this
class switch and ultimately an immediate
hypersensitive food pathogenesis continue to
be a major focus for research investigators.
Tolerance to Food Allergens
The defense against hypersensitivities to
dietary proteins is a well-developed, multitier
system dependent on an effective mucosal
barrier in association with the oral tolerance
generated by the cellular immune system of
the GALT. The balance between tolerance
(suppression) and sensitization (priming)
depends on several factors, such as genetic
background, nature and dose of antigen, fre-
quency of administration, age at ﬁrst antigen
exposure, immunologic status of the host,
and antigen transmission via breast milk
(Strobel 2002). However, the neonatal period
is particularly critical in terms of mucosal
defense. The intestinal barrier and function
provided by secretory antibodies and the
immunoregulatory network are poorly devel-
oped for a variable period after birth
(Brandtzaeg 2002).
In the healthy adult, the mucosal lining
of the gastrointestinal tract provides a physi-
cal barrier, preventing uptake of large mole-
cules. Small quantities of intact proteins that
do reach the GALT are controlled by an
active suppressor cell activity, producing oral
tolerance. However, for reasons yet to be
deﬁned, individuals with a genetic predispo-
sition to atopy respond to harmless food
proteins in an abnormal manner, producing
food allergy.
Food Allergy
Food allergy is commonly deﬁned as clinical
symptoms that result from an inappropriate
immune response to food proteins or
food additives (Burks and Stanley 1998).
Sensitization and the subsequent allergic
response to IgE-mediated food allergy are
generally identiﬁed as a multifactorial process,
involving a genetic predisposition (the atopic
syndrome) combined with environmental fac-
tors, that generates allergenic determinants
during food processing and/or intestinal
digestion and antigen processing by the
immune system. Normally, proteins are read-
ily digested and absorbed, leading to oral tol-
erance; however, through some intrinsic
property of the protein and/or a breakdown
in the intestinal epithelial barrier, there is an
enhancement of protein-induced antigenicity
and allergenicity.
The immunopathogenesis of food allergies
may be governed by more than one immuno-
logic mechanism, including immediate mani-
festations mediated by IgE; inflammatory
reactions caused by immune complexes,
lectins, and superantigens; and delayed hyper-
sensitivity reactions associated with specific
T lymphocytes (Helm and Burks 2000).
Predisposing factors for food allergy include a
genetic predisposition to atopy, the introduc-
tion of food before epithelial gastric mucosal
barrier closure, an immature GALT immune
system, feeding poorly digestible proteins,
incomplete digestion, increased mucosal
permeability, decreased IgA secretion, and
deranged cell-mediated responses of the
GALT.
True prevalence of adverse food reactions
is unknown; however, a review of the literature
indicates that approximately 6–8% of children
and 1–2% of adults have some type of food
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Food allergy can present as immediate hypersensitivity [manifestations mediated by immunoglobulin
(Ig)E], delayed-type hypersensitivity (reactions associated with speciﬁc T lymphocytes), and inﬂam-
matory reactions caused by immune complexes. For reasons of ethics and efﬁcacy, investigations in
humans to determine sensitization and allergic responses of IgE production to innocuous food pro-
teins are not feasible. Therefore, animal models are used a) to bypass the innate tendency to develop
tolerance to food proteins and induce speciﬁc IgE antibody of sufﬁcient avidity/afﬁnity to cause sen-
sitization and upon reexposure to induce an allergic response, b) to predict allergenicity of novel pro-
teins using characteristics of known food allergens, and c) to treat food allergy by using
immunotherapeutic strategies to alleviate life-threatening reactions. The predominant hypothesis for
IgE-mediated food allergy is that there is an adverse reaction to exogenous food proteins or food pro-
tein fragments, which escape lumen hydrolysis, and in a polarized helper T cell subset 2 (Th2) envi-
ronment, immunoglobulin class switching to allergen-specific IgE is generated in the immune
system of the gastrointestinal-associated lymphoid tissues. Traditionally, the immunologic character-
ization and toxicologic studies of small laboratory animals have provided the basis for development
of animal models of food allergy; however, the natural allergic response in large animals, which
closely mimic allergic diseases in humans, can also be useful as models for investigations involving
food allergy. Key words: allergens, atopic dog, gastrointestinal food allergy, swine. Environ Health
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most common food allergens in childhood are
cow’s milk, eggs, peanuts, soybeans, wheat,
fish, and tree nuts. In adults, peanuts, tree
nuts, ﬁsh, and shellﬁsh are the most common
sources of food allergy. Children by 3–5 years
of age can outgrow their food allergy, typically
to milk, eggs, soybeans, and wheat. Diet and
geographic location are also considered to be
factors contributing to food allergy in both
children and adults (Burks 2002).
Diagnosis of Food Allergy
The diagnostic assessment of IgE-associated
food allergy is based on clinical histories,
skin prick tests, allergen-specific IgE, and
the double-blind, placebo-controlled food
challenge (DBPCFC) (Bock 2000; Sampson
and Ho 1987). However, a proper clinical
history in which the food can be identiﬁed is
often sufficient to diagnose food allergy.
Prick-puncture skin tests have been shown
to have a high negative predictive accuracy
for major foods compared with a low posi-
tive predictive value. This is often variable
with age of the individual and quality of the
food extracts. Similar to skin testing, in vitro
testing for allergen-speciﬁc IgE is quite vari-
able, especially with quality of food extracts
and the interference from high total IgE and
IgG. The DBPCFC is considered the gold
standard for diagnosing adverse food reac-
tions caused by any mechanism. In combi-
nation a good clinical history, skin tests,
allergen-specific IgE levels, and the
DBPCFC, a diagnosis of a food as the agent
causing an adverse IgE-mediated event can
be made (Sampson 1989).
Food Allergen Characterization
The traditional deﬁnition of an allergen is
the ability of an antigen to produce an aller-
gic reaction by inducing speciﬁc IgE antibody
formation. Specifically, immunogenicity
involves formation of antibodies (IgM, IgG,
IgA) or cellular immunity, whereas allergenic-
ity is the ability of allergens to induce speciﬁc
IgE antibody of sufficient avidity/affinity
to cause sensitization and, upon re-exposure,
the ability to induce an allergic response.
Allergens have been defined as either com-
plete or incomplete. Complete allergens have
the following distinct molecular properties:
sensitization (the ability to induce the
immune system to produce IgE antibody),
elicitation (the ability to trigger allergic symp-
toms), and binding to allergen-specific IgE.
An incomplete allergen is defined as a non-
sensitizing protein that is able to elicit allergic
symptoms (Aalberse 2000). In determining
food protein allergenicity, two essential deﬁn-
itions must be considered: (a) sensitization—
the ability to induce the formation of IgE
antibody, and (b) the allergic reaction—the
property of a protein to cross-link cell-bound
specific IgE to elicit an allergic reaction by
releasing mediators, for example, histamine
(i.e., the ability to trigger symptoms upon re-
exposure).
The characteristics and what determines
that a common food protein will be recognized
by the gastrointestinal immune system as an
allergen are largely unknown. However, in the
assessment of food protein allergenicity, char-
acterization of the allergen should include an
accumulation of physicochemical, immuno-
chemical, and biochemical information based
on known food allergen characteristics
(Aalberse 2000; Kimber et al. 1999).
What is in agreement is that an allergen
has some or all of the following characteris-
tics: solubility (in the case of food allergy, the
ability to cross the gut mucosal barrier), sta-
bility (heat and digestive enzyme resistance),
and structure (surface molecule exposure).
Allergens must contain B-cell epitopes to
which IgE can bind, and T-cell epitopes
capable of inducing type 2 T-lymphocyte
responses. Although important to clinical
responses, T- and B-cell epitopes alone are
insufficient to endow a protein with aller-
genic potential. Careful consideration should
also be given to post-translational glycosyla-
tion and function, for example, enzymatic
activity, pathogenesis related-proteins, and
contractile proteins (protein families).
Relative stability of proteins in simulated
gastric ﬂuid and simulated intestinal ﬂuid can
often correlate with allergenic activity
(Astwood et al. 1996). Post-translational mod-
ification appears to enhance allergenicity by
increasing uptake and detection by the
immune system. Functional activity, particu-
larly enzyme activity, may also enhance aller-
genicity by nonspecific activation of cells
participating in the immunologic response, for
example, the induction of inflammation. By
better deﬁning the limits within which these
factors operate, we may be in a better position
to identify and characterize the hazards and
risks of allergic disease associated with novel
proteins (Huby et al. 2000).
Genetically Modiﬁed
Organisms and Food Allergy
The advent of bioengineered food crops in
1996 resulted in the recognition of the
potential to introduce known food allergens
or novel proteins that could be allergenic.
Agribiotech ofﬁcials and food safety regulatory
agencies (U.S. Department of Agriculture,
Environmental Protection Agency, and Food
and Drug Administration) began to evaluate
the safety of genetically modified foods that
would end up in our food supply. Task forces,
workshops, and food safety agencies took the
initiative to develop decision trees to assess
the potential allergenicity of (biotechnology-
derived) novel proteins (Metcalfe et al.
1996; Taylor et al. 2002). The participants
recognized that direct, indirect, or unin-
tended effects of genetic modification in
plants through classical or modern biotechno-
logic means should be evaluated to ensure the
safety of our food supply. At present, there is
no validated animal model or in vitro proto-
col for evaluating or predicting the allergic
risk of proteins newly introduced into our
food supply by either classical or modern
biotechnology.
As identiﬁed by Wal (1999), the questions
raised should be (a) whether it is possible to
assess or predict an allergenic risk from any
characteristic of the protein—for example, pri-
mary/secondary/tertiary structure, function,
origin, physicochemical properties, and as yet
unidentiﬁed characteristics; and (b) whether a
“new” protein produced by modern biotech-
nology, such as recombinant proteins
expressed by genetically modiﬁed organisms,
can be intrinsically more allergenic than a “nat-
ural” conventional protein. It seems reasonable
to state that allergenicity of a food protein can-
not be predicted by the analysis of crude prod-
uct, but that a physiologic basis of antigen
transport and modification by the organism
must be taken into account (Helm 2002a).
Criteria are continually being re-evaluated and
updated to help agribiotech ofﬁcials determine
potential allergenicity of novel proteins.
Animal Models
For reasons of ethics and efﬁcacy, prospective
sensitization studies in humans are not possi-
ble. Therefore, what is needed for the assess-
ment of novel proteins, especially novel
biotechnologically modiﬁed proteins, are ani-
mal models that mimic allergic responses in
humans. At present, no validated animal
model is available for determining the sensi-
tizing threshold of food allergens that can be
extrapolated to or predictive of the human
allergic response. Animal models are being
used to assess very different mechanisms:
a) mechanistic approaches to the understand-
ing of IgE-mediated disease, b) prophylactic
and intervention therapeutic approaches to
treat food allergy, and c) a qualitative
approach to determine the allergenicity of
novel proteins compared with known food
allergens. Traditionally, the immunologic
characterization and toxicologic studies of
small laboratory animals have provided the
basis for development of animal models of
food allergy [mouse (Atherton et al. 2002),
rat (Knippels and Penninks 2002), guinea pig
(Piacentini et al. 1994)]. However, the nat-
ural allergic response in large animals—the
dog (Buchanan and Frick 2002) and swine
(Helm 2002b)—that closely mimic allergic
diseases in humans can be useful models for
investigations involving food allergy.
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The following information represents a
summation of discussions from various
workshops and national meetings concerning
the issues of animal models, to which the
author (R.M.H.) was a participant (NCFST
2000; Health Canada 2001; Society of
Toxicology 2001; ILSI/HESI 2000; FAO/
WHO 2001). Several methods have been
introduced to bypass the state of tolerance and
initiate a food hypersensitivity that reflects
human IgE-mediated food allergy. In general,
animal models of gastrointestinal food allergy
have required nonphysiologic routes of anti-
gen/allergen presentation and the use of adju-
vants inducing Th2 cytokines. Most animal
models, including small laboratory animals
(mice, rats, and guinea pigs) and domestic
animals (dogs, pigs, and calves), use intra-
venous, intraperitoneal, subcutaneous, or the
intradermal route of administration with or
without an adjuvant.
The degree of sensitization should take
into consideration the following parameters:
a) the concentration of the allergen (high
doses are known to induce tolerance; however,
the high-dose tolerance/low-dose sensitization
is relative to the host and the antigen/allergen
source); b) that the allergen should be taken in
context with the food source; c) the route
(feeding and/or gavage are the recommended
avenues) and duration (time course may vary
with respect to species and allergen) of aller-
gen exposure; d) age of the animal (neonate,
adolescent, adult), e) a genetic predisposition
(high and low IgE responders); f) the use of
adjuvants (natural or artiﬁcial—alum, cholera
toxin, Bordetella pertussis, and carrageenan are
known IgE-selective adjuvants); g) isotype
specificity response (mice respond with two
anaphylactic antibodies, IgG1 and IgE; rats
with IgG2a and IgE; guinea pigs with IgG1
and IgE; dogs with IgE; and pigs, likely with
IgE); and h) the Th1/Th2 regulation/polariza-
tion (mice have very delineated Th1/Th2
polarization, whereas in humans polarization
is not as discrete).
In addition, the animal model should
demonstrate dose dependence to a wide range
of food allergens without responding to non-
allergens in the production of IgE, compara-
ble with what is seen in humans. The
allergenicity profile should be comparable
with what exists in the human response to
different allergens, for example, anaphylactic
episodes induced by peanut allergens or
oral/pharyngeal symptoms elicited by fruit
and vegetable allergens in the oral allergy syn-
drome. The simple production of IgE (analy-
sis by in vitro methods, i.e., enzyme-linked
immunoadsorbent assay) and binding of IgE
to relevant proteins (sodium dodecyl
sufate–polyacrylamide gel electrophoresis/
immunoblot analysis) should be considered
insufﬁcient to establish a protein as an aller-
gen without clinical relevance. Evidence of
histamine release by skin prick test or using
in vitro tests to support cross-linking of IgE
to bound mast cells and basophils should also
be considered. However, the demonstration
of a positive test in any of these methods
should raise warning signals as to the poten-
tial allergenicity of a novel protein.
Consideration should also be given to the
differential induction and regulation of
cytokines (Th1/Th2 cytokine profile),
immunoglobulins (IgA, IgG, and IgE), and
chemokine production by different antigen-
presenting cells between the species under
investigation. Additionally, concentration and
exposure of the food, the physiologic basis of
the gastrointestinal tract environment, anti-
gen transport, and modification of the food
source (heat treatment, roasting) should be
taken into account. These factors include the
lumen hydrolytic environment and the degra-
dation by digestive enzymes of the host and
commensal ﬂora, and the uptake, processing,
and presentation of proteins by the immune
systems under investigation.
In the remainder of this article, an
overview of the atopic dog and neonatal swine
is presented, demonstrating the evidence in
favor of these nonmurine animal models for
determining food protein allergenicity. All ani-
mals used in the studies were maintained
according to Animal Welfare Act and National
Research Council regulations, as well as stan-
dards of the respective Institutional Animal
Care and Use Committees. Advantages and
disadvantages of large animal models are
presented in Table 1.
Atopic Dog Model
In canine allergy, the most common clinical
presentation is a nonseasonal generalized pru-
ritis with or without lesions with papular
eruptions in about 40% of cases (Reedy et al.
1997). Flea allergy and general atopy precede
food allergy as the most common types of
allergic disease in dogs (Reedy et al. 1997).
About 8% of the canine population is
affected by food allergy, with no age, sex, or
breed being a predisposing factor (Baker
1974, 1990; Jeffers et al. 1991; White 1986,
1988). The incidence of spontaneous food
and inhalant allergy in dogs is comparable
with the approximately 10% incidence of
allergy in humans. The clinical signs, which
vary from gastrointestinal reactions (vomiting
and diarrhea) to dermatologic reactions (pru-
ritis, papules, and erythema), are symptoms
of food allergy in both humans and dogs
without predisposing factors such as age, sex,
or breed of canines (Baker 1990; Jeffers et al.
1991; Halliwell 1992; August 1985; White
1986, 1988).
Food hypersensitivity may contribute to
pruritis in up to 62% of dogs presenting with
allergic skin disease (Leib and August 1989).
It has been estimated that 10–15% of dogs
with dermatologic signs may have concurrent
gastrointestinal signs, which include emesis,
diarrhea, bloating, and cramping (Carlotti et
al. 1990). Multiple food allergies have been
identiﬁed as presenting with primary gastroin-
testinal disease symptoms. Foods responsible
for allergy in dogs include milk, soybean,
wheat, oats, beef, eggs, chicken, horsemeat,
cornmeal, pork, yeast, and commercial foods
with varying protein bases.
Diagnosis in dogs can be made by dietary
restriction and rechallenge similar to the
DBPCFC (dogs have no preconception of
food allergy) (Strombeck and Guilford 1990).
In a frequency study of food allergy identiﬁed
by single-ingredient provocation testing in
25 dogs with histories and cutaneous signs
consistent with a food allergy, Jeffers et al.
(1991) confirmed food ingredients in soy,
chicken, milk, corn, wheat, and eggs pro-
voked adverse cutaneous reactions. As in
humans, the clinical signs in dogs sensitive to
different foods were variable, including skin,
gastrointestinal, respiratory, and central ner-
vous system effects and combinations of these
pathologic conditions.
A high IgE-producing spaniel/basenji dog
colony with histories of sensitivity to pollens
and foods has been used for studies into
immunologic mechanisms (Ermel et al. 1993,
1994, 1997; Frick et al. 1994). The atopic dog
model mimics a proposed mechanism involved
in the development of food allergies in chil-
dren, that of a viral infection combined with
sensitization to other nonviral-related protein.
In genetically predisposed individuals with an
initial early infection or viral challenge, the
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Table 1. Advantages/disadvantages of nonrodent animal food allergy models.
Advantages Disadvantages
Conﬁrmed clinical/immunologic of natural food allergy Limited species/strains
Anatomy/physiology/nutritional requirements Knockout strains not available
similar to those of humans
Immunopathogenic/mechanistic/therapeutic intervention strategies Lack of complete array of immunologic
similar to those for humans reagents
Repeated endoscopic analysis of gastrointestinal tract Large size and smaller experimental
animal numbers/group
Large size/numbers of primary and secondary immune organs/cells Expensive to maintain colonies
Smaller concentration of sensitizing antigen/allergen per gram
of body weightimmune system is suggested to be capable of
responding to “bystander” antigens with more
vigor. The inﬂamed gut becomes more perme-
able to proteins, thereby exposing the local
immune system to more antigen sources.
In the atopic dog model for food allergy
(Ermel et al. 1997), newborn pups (day 1)
were subcutaneously injected in the axillas
with 1 µg of cow’s milk, beef, ragweed, and
wheat extracts in alum. Food antigen was
again administered on days 22, 29, 50, 78,
and 85. At ages 3, 7, and 11 weeks, all pups
were vaccinated with attenuated distemper-
hepatitis vaccine. Immunized pups responded
with allergen-specific IgE by week 3 and
peaked at week 26 of age. The IgE titer could
be maintained with bimonthly injections of
specific antigen in alum combined with a
daily feeding of a maintenance diet containing
minimal amounts of the allergen source.
Oral challenge with food antigens demon-
strated clinical manifestations of food allergy.
Nausea and vomiting were evident within 1
hr and mild to severe diarrhea within 12 hr
that resolved within 3–4 days. Systemic clini-
cal signs included pruritis, facial edema, con-
junctivitis, dermatitis, and anaphylaxis.
Intradermal skin tests were consistently posi-
tive when challenged with the relevant aller-
gen and negative with an irrelevant allergen
(nonimmunized allergen). Positive skin tests
appeared to correlate with speciﬁc food anti-
gen IgE titers, in that animals that had higher
IgE titers had better responses to intradermal
injections of specific food allergens. Serial
dilutions of each food allergy were used to
determine a relative end point as an indicator
of true allergenicity. All clinical manifestations
are consistent with infant, adolescent, and
adult food allergy in humans.
Gastroscopic food sensitivity tests on
animals receiving a hypoallergenic liquid
maintenance diet were performed under gen-
eral anesthesia (Ermel et al. 1997). Food aller-
gen extracts were injected into the gastric
mucosa, and the injection sites were moni-
tored and videotaped. Observable responses
were recorded within 3–5 min, ranging from
mild to moderate to severe erythema and
edema of the tissue sites. Gastroscopic food
sensitivity test responses were consistent and
reproducible in individual food-allergen–spe-
ciﬁc dogs. Endoscopic analysis of gastric food
sensitivity testing and histologic tissue exami-
nation revealed acute-phase inflammatory
responses with pronounced mucosal swelling
and persistent erythema at the site of injec-
tion. Congestion, interstitial edema, gastric
submucosal periglandular edema, and
increased LTB4 and PGE2 were in evidence
within 3–5 min postinjection. A late-phase
inflammatory response with gastric submu-
cosal epithelial vascular degeneration and neu-
trophil inﬁltration was identiﬁed at 24–48 hr
postinjection. In addition, late biopsy speci-
mens revealed evidence of eosinophil inﬁltra-
tion into the lamina propria and migration
through the endothelium. Skin testing and
oral challenges with peanut, walnut, Brazil
nut, wheat, cow’s milk, soy, and barley
revealed an allergenic proﬁle in the atopic dog
model identical to that in humans. An allergic
response profile indicates that peanuts and
tree nuts caused the most signiﬁcant and pro-
found allergic responses, followed by wheat,
cow’s milk, soy, and barley, respectively.
The differences in skin test titration end
points were also used to assess efﬁcacy of dif-
ferent treatments of allergenic foods to deter-
mine their relative allergenicity (Buchanan et
al. 1997; de Val et al. 1999). Thioredoxin
treatment of proteins in foods reduces intra-
chain disulfide bonds, disrupting structural
integrity. Wheat gliadins and glutenins, cow’s
milk β-lactoglobulin, soybean trypsin
inhibitor, and glutenins treated with thiore-
doxin showed evidence of allergenic activity
reduced 10–1,000-fold compared with native
nontreated extracts by end-point skin test
titration. Oral feeding challenges with thiore-
doxin-treated β-lactoglobulin or milk caused
minimal or no gastrointestinal symptoms
compared with native allergens. This suggests
that structural integrity of some food aller-
gens is necessary for sensitization.
The atopic dog model has also been used
to test and compare the allergenicity of a
transgenic corn line (corn genetically modi-
ﬁed to produce a novel protein) with that of a
nontransgenic corn (Buchanan BB. Personal
communication). Peanut, soy, cow’s milk,
and ragweed allergens were used as positive
controls, and the nontransgenic corn was
used as a negative control for the genetically
modified corn. Among the allergens tested,
peanut provided the strongest IgE-mediated
response, which developed rapidly early in
the sensitization/allergic response and
remained constant from 9 to 23 months of
age. Responses to cow’s milk and ragweed
progressed slowly by 9 months and rose sig-
niﬁcantly by 18–23 months. Soybean showed
the strongest response by 9 months, which
became weaker by 18–23 months. These
responses conﬁrmed earlier responses demon-
strating a similar allergenic potency proﬁle in
human food allergy; that is, soybean and milk
allergy is common in infants and wanes in
adolescence/adulthood, whereas peanut nor-
mally is considered a life-long food allergy.
The transformed corn extract caused no
skin responses at 9 and 18 months, and mini-
mal response by 23 months corresponding to
1/5,000th that of peanut, 1/9,000th that of
ragweed, 1/700th of cow’s milk, and 1/50th
that of the soybean. Furthermore, after 23
months, the transgenic corn protein showed
no evidence of skin reactions in dogs sensitized
to transgenic corn extract when tested at
5–380-fold higher concentrations than the
amount present in the parent corn extract.
Neonatal Swine Model
Swine present a number of important
advantages compared with other animal
models for investigating the pathogenesis
and immune responses to allergens; they
closely resemble humans in gastrointestinal
physiology and in the development of
mucosal immunity. Developing piglets have
similar anatomy and nutritional require-
ments, a transient neonatal porosity to the
gut to dietary proteins, a distribution and
maturation of intestinal enzymes, and an
enteric absorption of antibody that is similar
to that of the developing infant. In addition,
they are born immunocompetent, allowing
for assessment of immune responses
(Phillips and Tumbleson 1986).
Investigations in swine and calves
demonstrate the induction of hypersensitivity
responses that are similar to those of human
allergic disease (Barratt et al. 1978). Studies in
veterinary medicine have shown swine to have
an IgE-mediated-like response to parasites,
legumes, and pollens reminiscent of that in
humans (Barratt et al. 1978; Bailey et al. 1994;
Hankins et al. 1992; Heppel et al. 1989; Li et
al. 1991; Rees et al. 1989; Wilson et al. 1989).
Young piglets have been used as models for
sensitization/tolerance to cow’s milk and soy
proteins, which parallel what is seen in young
children (Bailey et al. 1994; Hankins et al.
1992; Heppel et al. 1989; Li et al. 1991; Rees
et al. 1989; Wilson et al. 1989).
Moreover, gastrointestinal-associated
adverse immunologic reactions include eme-
sis, diarrhea, bleeding, and weight loss, which
are also associated with human gastrointesti-
nal allergy. A reduced growth performance in
pigs fed soybean proteins has been associated
with reduced weight gain and protein
digestibility, which may be caused by a hyper-
sensitivity to soybean proteins, glycinin, and
β-conglycinin.
Considering these data and the similarities
in digestive function in the neonatal pig and
the developing child, a peanut food allergy
model in young piglets was established to
investigate gastrointestinal hypersensitivity to
peanuts (Helm et al. 2002). The objective of
the study was to evaluate gross physical appear-
ance and a microscopic analysis to tissues from
dissection and endoscopy, determine a histo-
logic profile and obtain a molecular analysis
from tissues for evidence of a Th1/Th2
cytokine profile, and perform immunologic
tests to determine the relative state of the
immune response.
A series of intragastric and intraperitoneal
sensitizations followed by oral challenge with
peanut materials was undertaken to achieve an
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Preliminary investigation demonstrated that
approximately 25% of intragastrically sensi-
tized animals and 75–90% of intraperitoneally
sensitized animals responded to an oral
challenge of peanut meal. Thus, an optimal
experimental regime using intraperitoneal
administration of peanut extract and oral chal-
lenge with peanut meal was developed as
follows. Outbred Large White/Landrace preg-
nant sows at day 108 of gestation were
allowed to farrow and nurse under normal
conditions on a soybean/peanut-free diet.
Piglets at days 9–11, 17, and 25 of age were
intraperitoneally sensitized with 500 µg of
peanut extract with 100 µg cholera toxin.
Two animals in each litter were selected to
receive control treatment—phosphate-
buffered saline (PBS) and PBS with 100 µg of
cholera toxin, respectively. On an allergen/
body weight basis, in both the atopic dog
model and the swine model, this is far less
than that used for smaller laboratory animals.
Intragastric challenge with peanut meal or
intradermal skin testing was performed on
alternating weeks starting 2 weeks after the
ﬁnal sensitization. Blood was drawn at weekly
intervals to assess immune responses to the
sensitization protocol.
Oral challenges on days 39 and 53 with
10 or 20 g of peanut meal respectively
resulted in symptoms in 75–100% of animals
by the second oral challenge within 30–60
minutes of the challenge. A positive response
included emesis, malaise, tremors, and con-
vulsions with major and minor rashes.
Physical evidence of respiratory distress and
anaphylactic shock was identiﬁed in approxi-
mately 10–20% of sensitized animals. No
animals were allowed to proceed to death as a
result of anaphylactic shock. Treatment with
epinephrine was administered when respira-
tory distress was evident to alleviate all symp-
toms. Repeated oral challenges up to day 90
resulted in sensitized animals that responded
with increasing degrees of physical symptoms.
Control animals receiving either PBS or
PBS/cholera toxin challenged with peanut
meal did not respond with any physical
symptoms of gastrointestinal or systemic
allergy. Peanut-sensitized animals challenged
with soybean/peanut-free diet failed to show
any symptoms.
Skin tests with crude peanut extracts on
alternating weeks confirmed the persistence
of the allergic state throughout a 14-week
period. In addition, both the native and
recombinant forms of the major peanut
allergens, Ara h 1 and Ara h 2, induced a
positive skin test compared with rice allergen
extracts. Skin prick tests with 12–1,000 µg
of peanut extracts intradermally were posi-
tive (wheal and flare > 5–15 mm); PBS and
PBS/cholera toxin control administrations
were negative (2 mm), and histamine was
≥ 15 mm in peanut-sensitized animals. In
nonpeanut-sensitized animals, the histamine
showed positive wheal and flares, whereas
the peanut extracts showed < 3 mm wheal
and ﬂare reactions.
Immunologically, the animals were
assessed for the production of antigen-speciﬁc
IgG, IgE by passive cutaneous anaphylaxis,
peripheral blood lymphocyte proliferative
responses to antigen, and CBC/differentials.
Peanut-specific IgG values measured in
peanut-sensitized animals reached levels
> 1,000 µg/mL (range, 26–7,700 µg/mL)
by day 37 and maintained values of
> 500 µg/mL (range, 51–1,500 µg/mL) at
day 60. Peanut-speciﬁc IgG varied from litter
to litter and within each litter; however, the
course of the immune response to peanut was
similar. Nonpeanut-sensitized animals had
< 50 µg/mL antigen-speciﬁc IgG.
To confirm that IgE is the responsible
isotype inducing the allergic symptoms, pas-
sive cutaneous anaphylaxis tests were per-
formed in naive animals. One hundred
microliters of nonheated and serial heat-inac-
tivated serum from peanut-sensitized pigs was
administered intradermally into the flank of
naive (nonpeanut-sensitive) animals. Twenty-
four hours later, 5 mg of peanut extract in
1.0 mL PBS was administered by intravenous
injection, and the response was read 30 min
later. Intradermal skin sites with the nonheat-
inactivated serum responded with a wheal
and flare > 10 mm at the site of injection,
whereas heat-inactivated serum showed no
reaction, confirming that native IgE was
responsible for the reaction.
A substantial increase in neutrophil early
band forms mirrored the recruitment of these
cells seen in food-sensitive individuals after an
oral challenge to the offending food. In pro-
liferation assays, peripheral blood lympho-
cytes showed a 3–5-fold increase in tritiated
thymidine uptake compared with media and
rice protein controls.
Gastrointestinal tract analysis at the time
of sacrifice after oral challenges revealed
minor amounts of peanut meal in the stom-
ach and intestine of peanut-sensitized ani-
mals that vomited compared with abundant
quantities of soybean/peanut-free meal in
peanut-sensitized animals or peanut meal in
nonsensitized animals. The most prominent
histologic ﬁndings were vascular congestion,
hemorrhage, and epithelial denudation that
occurred primarily in the proximal small
intestine. The cellular phenotype in the small
intestine consisted primarily of lymphocytes
and plasmacytes. Other acute markers
included mucus extrusion and submucosal
edema in the stomach. The colon was nor-
mal in most piglets, with occasional vascular
congestion and crypt abscesses.
Conclusion
Several animal models are being used to
determine the mechanisms of IgE production;
however, a validated animal model for deter-
mining which proteins are allergenic, that is,
what characteristics or traits of novel proteins
are predictive for the induction of IgE com-
pared with nonallergen source material, is
needed for controlled studies. Moreover,
extrapolation to the human response to a pro-
ﬁle of strong to weak food allergens and non-
food allergen proteins is incomplete. In both
the atopic dog and the neonatal swine models
for food allergy, substantial evidence and data
for clinical and immunologic findings in
hypersensitized animals support continued
research. Both animal models are character-
ized by an underlying natural mechanism of
allergy that contributes to their usefulness as
models for further characterization of the
immunopathogenesis of IgE-mediated food
allergy and investigations aimed at predicting
the allergenic nature of novel proteins in
biotechnologically derived food sources. The
continued research efforts in this area should
include not only the ability of a protein to
produce IgE but also clinical evidence of
symptomology characteristic of the human
allergic response, a ranking of the allergens
with respect to potency of proteins in food
allergy, and comparative studies with non-
food proteins.
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